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Angiotensin 1-7 Rescues Cognitive Decline and Neuronal Loss Following 
Traumatic Brain Injury in Mice  
 
Esther H. Bae, Michael Gaub, Dez Coleman, Alexander J. Sandweiss, Bellal Joseph, Tally M. 




Purpose of study: Traumatic brain injury (TBI) is a leading cause of death and disability in the U.S., 
accounting for approximately 30% of all injury deaths and 3 million TBI-related emergency visits 
yearly. There is limited research in the area of mitigating the post-inflammatory effects of non-fatal 
traumatic brain injury. Angiotensin 1-7, an endogenous peptide that acts on the MAS receptor, has 
recently shown to be anti-inflammatory, anti-oxidative, and vasodilatory unlike its relative, 
angiotensin II. We asked the question of whether Ang 1-7 modulates neuroinflammation and 
improves cognitive function in mice following traumatic brain injury.  
 
Methods: A controlled cortical impactor with a retractable piston was used to model a mild 
traumatic brain injury (mTBI). Mice either received Ang 1-7 (1 mg/kg, n=12) or normal saline 
(0.9%, n=12) 2 hours post-TBI and 30 minutes prior to novel objection recognition (NOR) testing 
on days 1, 3, 7, 14 post-TBI with tissue harvesting for hematoxylin and eosin (H&E) staining.  
 
Results: Between-group studies showed that Ang 1-7 treated mice showed significantly higher NOR 
ratios compared to that of the control group. Additionally, statistically significant higher neuronal 
count in the ipsilateral hippocampal and cortical tissues days 1, 3, 7, and 14 post-TBI was observed 
in the Ang 1-7 group.   
 
Conclusion: Together, these results demonstrate that Ang 1-7 significantly improves cognitive 
function and rescues further cell loss against secondary intrinsic injury following extrinsic mTBI and 
suggest that it may be a novel therapy to the effects of mild traumatic brain injury.  
 
 
